Please login to the form below

Not currently logged in
Email:
Password:

Acorda Therapeutics appoints chief medical officer

Interim CMO Dr Burkhard Blank takes on the post in a permanent capacity

New York-based biotech Acorda Therapeutics has appointed Dr Burkhard Blank as its chief medical officer.

Dr Blank has served in the role in a temporary capacity since January this year and now takes on the post permanently.

He brings over 25 years of industry experience to Acorda, and has held senior leadership positions at Altus Pharmaceuticals, Herantis Pharma and Laurantis Pharma.

Prior to this, Dr Blank worked at Boehringer Ingelheim, first as its global head for regulatory affairs before serving as its chief medical officer between 2001 and 2006.

Dr Ron Cohen, president and chief executive of Acorda, said: “I am delighted that Burkhard has joined Acorda as our chief medical officer.

“Burkhard brings to Acorda an impressive record of successful drug development and approved NDAs. This will benefit Acorda's entire pipeline, including our late-stage development programs, CVT-301 and tozadenant for Parkinson's disease.”

5th July 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics